Related Experiment Video

Updated: Sep 23, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Depression and congestive heart failure

Thomas P Guck1, Gary N Elsasser, Michael G Kavan

  • 1Department of Family Practice, Creighton University School of Medicine, Omaha, NE 68102, USA. tpguck@creighton.edu

Congestive Heart Failure (Greenwich, Conn.)
|June 27, 2003
PubMed

Insights

Depression affects 24%-42% of congestive heart failure patients, increasing risks for hospitalization and mortality. Effective treatments include cognitive-behavior therapy and selective serotonin reuptake inhibitors.

Area of Science:

  • Cardiology
  • Psychiatry
  • Clinical Medicine

Background:

  • Depression is highly prevalent in congestive heart failure (CHF) patients, with rates between 24% and 42%.
  • Depression independently predicts adverse outcomes in CHF, including hospital readmission, functional decline, and mortality.
  • Accurate assessment and effective management of depression are crucial for improving CHF patient prognosis.

Purpose of the Study:

  • To review the prevalence, risk factors, and management strategies for depression in patients with congestive heart failure.
  • To highlight the impact of depression on clinical outcomes in CHF.
  • To provide evidence-based recommendations for pharmacological and psychological interventions.

Main Methods:

  • Literature review of studies on depression in congestive heart failure.
  • Analysis of diagnostic criteria and assessment tools for depression.
  • Evaluation of treatment efficacy for psychological and pharmacological interventions.

Main Results:

  • Depression is a significant and independent risk factor for adverse outcomes in CHF patients.
  • Cognitive-behavioral therapy (CBT) is the preferred psychological treatment.
  • Selective serotonin reuptake inhibitors (SSRIs) are recommended, while tricyclic antidepressants are not advised.
  • Combination therapy with SSRIs and CBT often yields the best results.

Conclusions:

  • Integrated management of depression is essential for optimizing care in CHF patients.
  • Early identification and treatment of depression can mitigate risks associated with CHF.
  • Further research into tailored interventions for this patient population is warranted.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...